US6090947A
(en)
|
1996-02-26 |
2000-07-18 |
California Institute Of Technology |
Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
|
CN1260006A
(zh)
|
1996-02-26 |
2000-07-12 |
加利福尼亚州技术学院 |
双链dna和杂环低聚物之间复合物的形成
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
ATE251913T1
(de)
*
|
1997-05-21 |
2003-11-15 |
Univ Leland Stanford Junior |
Zusammensetzung und verfahren zur verzögerung des transports durch biologische membranen
|
US7135191B2
(en)
*
|
1997-09-04 |
2006-11-14 |
Zsolt Istvan Hertelendy |
Urogenital or anorectal transmucosal vaccine delivery system
|
US6958148B1
(en)
*
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
IL138214A0
(en)
|
1998-03-09 |
2001-10-31 |
Zealand Pharmaceuticals As |
Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
US20040063618A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Muthiah Manoharan |
Peptide nucleic acids having improved uptake and tissue distribution
|
JP2002518521A
(ja)
|
1998-06-20 |
2002-06-25 |
ワシントン・ユニバーシティ |
医用画像解析、診断および治療のための膜透過性ペプチド錯体
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
US6589503B1
(en)
|
1998-06-20 |
2003-07-08 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
US7306784B2
(en)
|
1998-06-20 |
2007-12-11 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
CA2388991A1
(en)
*
|
1998-11-11 |
2001-04-19 |
Peter E. Nielsen |
Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino
|
US6548651B1
(en)
|
1998-11-11 |
2003-04-15 |
Pantheco A/S |
Modified peptide nucleic acid (PNA) molecules
|
DK173006B1
(da)
*
|
1998-11-11 |
1999-11-01 |
Ke Burgmann As |
Fremgangsmåde og anlæg til frembringelse af vægmateriale til brug ved fremstilling af kompensatorer, navnlig til røggaskanaler, samt kompensatormateriale og kompensator frembragt ved fremgangsmåden
|
US7018654B2
(en)
*
|
1999-03-05 |
2006-03-28 |
New River Pharmaceuticals Inc. |
Pharmaceutical composition containing an active agent in an amino acid copolymer structure
|
US7060708B2
(en)
|
1999-03-10 |
2006-06-13 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US6716452B1
(en)
*
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
NZ514592A
(en)
*
|
1999-04-05 |
2004-02-27 |
Millennium Pharm Inc |
Formulation arrays and use thereof
|
EP1656945A1
(de)
*
|
1999-06-05 |
2006-05-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pharmazeutische Zusammensetzung enthaltend Oligoarginin
|
IL141250A0
(en)
*
|
1999-06-05 |
2002-03-10 |
Univ Leland Stanford Junior |
Method and composition for inhibiting cardiovascular cell proliferation
|
MXPA02000890A
(es)
*
|
1999-07-28 |
2003-10-15 |
Transform Pharmaceuticals Inc |
Conjuntos de muestras y analisi de alto rendimiento de las mismas para detectar interacciones.
|
US20050226890A1
(en)
*
|
1999-08-12 |
2005-10-13 |
Cohen David I |
Tat-based vaccine compositions and methods of making and using same
|
KR100345214B1
(ko)
*
|
1999-08-17 |
2002-07-25 |
이강춘 |
생체적합성 고분자가 수식된 펩타이드의 비점막 전달
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
US6669951B2
(en)
*
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
AU769315B2
(en)
*
|
1999-08-24 |
2004-01-22 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
US6864355B1
(en)
|
2000-05-02 |
2005-03-08 |
Yale University |
Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
AU7773100A
(en)
*
|
1999-10-13 |
2001-04-23 |
Pantheco A/S |
Gene selection using pnas
|
AU765588C
(en)
|
1999-11-24 |
2004-12-16 |
Immunogen, Inc. |
Cytotoxic agents comprising taxanes and their therapeutic use
|
JP2003516151A
(ja)
*
|
1999-11-29 |
2003-05-13 |
エイブイアイ バイオファーマ, インコーポレイテッド |
細菌16Sおよび23SrRNAに標的化された、荷電していないアンチセンスオリゴヌクレオチド、ならびにその使用
|
WO2001049775A2
(en)
*
|
2000-01-04 |
2001-07-12 |
Avi Biopharma, Inc. |
Antisense antibacterial cell division composition and method
|
US6977723B2
(en)
|
2000-01-07 |
2005-12-20 |
Transform Pharmaceuticals, Inc. |
Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
|
US7108970B2
(en)
|
2000-01-07 |
2006-09-19 |
Transform Pharmaceuticals, Inc. |
Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
|
US20020009491A1
(en)
*
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
AU2001238346A1
(en)
|
2000-02-15 |
2001-08-27 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
US6749865B2
(en)
|
2000-02-15 |
2004-06-15 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
US7078536B2
(en)
|
2001-03-14 |
2006-07-18 |
Genesoft Pharmaceuticals, Inc. |
Charged compounds comprising a nucleic acid binding moiety and uses therefor
|
DE60128551D1
(de)
|
2000-03-16 |
2007-07-05 |
Genesoft Inc |
Geladene verbindungen mit einer nukleinsäure-bindenden einheit sowie deren verwendungen
|
AU2001248281A1
(en)
*
|
2000-04-06 |
2001-10-23 |
Pantheco A/S |
Pharmaceutical composition of modified pna molecules
|
GB0008563D0
(en)
|
2000-04-07 |
2000-05-24 |
Cambridge Discovery Chemistry |
Investigating different physical and/or chemical forms of materials
|
US7049395B2
(en)
|
2000-05-02 |
2006-05-23 |
Yale University |
Anti-inflammatory compounds and uses thereof
|
KR20020097241A
(ko)
|
2000-05-04 |
2002-12-31 |
에이브이아이 바이오파마 인코포레이티드 |
스플라이스-영역 안티센스 조성물 및 방법
|
US20040220100A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
DK2364734T3
(en)
*
|
2000-07-21 |
2017-10-30 |
Revance Therapeutics Inc |
Biological multicomponent transport systems
|
WO2005090392A1
(en)
*
|
2004-03-16 |
2005-09-29 |
Inist Inc. |
Tat-based tolerogen compositions and methods of making and using same
|
WO2006033665A1
(en)
*
|
2004-03-16 |
2006-03-30 |
Inist Inc. |
Tat-based vaccine compositions and methods of making and using same
|
US7163918B2
(en)
|
2000-08-22 |
2007-01-16 |
New River Pharmaceuticals Inc. |
Iodothyronine compositions
|
US20020099013A1
(en)
*
|
2000-11-14 |
2002-07-25 |
Thomas Piccariello |
Active agent delivery systems and methods for protecting and administering active agents
|
US20050059031A1
(en)
*
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
EP2085781B2
(de)
*
|
2000-10-06 |
2020-03-11 |
Life Technologies Corporation |
Zellen mit spektralen Signaturen und Verfahren zur Herstellung und Verwendung davon
|
US7033597B2
(en)
*
|
2000-10-13 |
2006-04-25 |
Université de Lausanne |
Intracellular delivery of biological effectors
|
GB0026924D0
(en)
|
2000-11-03 |
2000-12-20 |
Univ Cambridge Tech |
Antibacterial agents
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
JP2004514427A
(ja)
*
|
2000-11-24 |
2004-05-20 |
パンセコ・アクティーゼルスカブ |
Pna類似物
|
WO2002053574A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Pantheco A/S |
Modified pna molecules
|
US7585834B2
(en)
|
2001-02-16 |
2009-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Transporters comprising spaced arginine moieties
|
US6825166B2
(en)
|
2001-03-23 |
2004-11-30 |
Tapestry Pharmaceuticals, Inc. |
Molecular conjugates for use in treatment of cancer
|
WO2002088119A1
(en)
|
2001-04-26 |
2002-11-07 |
Genesoft Pharmaceuticals, Inc |
Halogen-substituted thienyl compounds
|
AU2002312371A1
(en)
|
2001-06-13 |
2002-12-23 |
Roland W. Burli |
Aryl-benzimidazole compounds having antiinfective activity
|
US6777425B2
(en)
|
2001-06-13 |
2004-08-17 |
Genesoft Pharmaceuticals, Inc. |
Isoquinoline compounds having antiinfective activity
|
EP1470119A4
(de)
|
2001-06-13 |
2005-10-19 |
Genesoft Pharmaceuticals Inc |
Benzothiophenverbindungen mit antiinfektiver wirkung
|
WO2002101007A2
(en)
|
2001-06-13 |
2002-12-19 |
Genesoft Pharmaceuticals, Inc |
Antipathogenic benzamide compounds
|
US7033991B2
(en)
*
|
2001-07-16 |
2006-04-25 |
Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College |
Inhibiting furin with polybasic peptides
|
US8815793B2
(en)
*
|
2001-07-20 |
2014-08-26 |
Northwestern University |
Polymeric compositions and related methods of use
|
US7858679B2
(en)
*
|
2001-07-20 |
2010-12-28 |
Northwestern University |
Polymeric compositions and related methods of use
|
US7618937B2
(en)
*
|
2001-07-20 |
2009-11-17 |
Northwestern University |
Peptidomimetic polymers for antifouling surfaces
|
MXPA04001142A
(es)
*
|
2001-08-03 |
2004-09-13 |
Univ Leland Stanford Junior |
Sintesis bidireccional de agentes de transporte de oligoguanidina.
|
US20060264608A1
(en)
*
|
2001-08-03 |
2006-11-23 |
Wender Paul A |
Bi-directional synthesis of oligoguanidine transport agents
|
EP1425577A4
(de)
|
2001-08-10 |
2004-12-29 |
Symyx Technologies Inc |
Vorrichtungen und verfahren zur erzeugung und zum testen von präformulierungen sowie systeme dafür
|
US7338939B2
(en)
*
|
2003-09-30 |
2008-03-04 |
New River Pharmaceuticals Inc. |
Abuse-resistant hydrocodone compounds
|
US20070066537A1
(en)
*
|
2002-02-22 |
2007-03-22 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US20060014697A1
(en)
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
US7375082B2
(en)
*
|
2002-02-22 |
2008-05-20 |
Shire Llc |
Abuse-resistant hydrocodone compounds
|
US7169752B2
(en)
*
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
EP1446008A4
(de)
*
|
2001-10-18 |
2006-08-16 |
Essentia Biosystems Inc |
Zusammensetzungen und verfahren zur gesteuerten freisetzung
|
MXPA04005611A
(es)
|
2001-12-11 |
2005-04-19 |
Cellgate Inc |
Reactivos y conjugados de transporte de guanidinio.
|
WO2003059192A2
(en)
|
2001-12-21 |
2003-07-24 |
The Trustees Of Columbia University In The City Of New York |
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis
|
DE10201862A1
(de)
*
|
2002-01-18 |
2003-08-07 |
Deutsches Krebsforsch |
Konjugat zur Behandlung prokaryontischer Infektionen
|
US7026166B2
(en)
|
2002-01-22 |
2006-04-11 |
Chiron Corporation |
Fluorogenic dyes
|
US20050181474A1
(en)
*
|
2002-01-30 |
2005-08-18 |
Frank J. Giordano |
Transport peptides and uses therefor
|
EP1572902B1
(de)
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HOCHWIRKSAME siRNAS ZUR REDUZIERUNG DER EXPRESSION VON ZIELGENEN
|
ATE508188T1
(de)
|
2002-02-01 |
2011-05-15 |
Life Technologies Corp |
Oligonukleotid-zusammensetzungen mit verbesserter wirksamkeit
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
ES2500117T3
(es)
*
|
2002-02-22 |
2014-09-30 |
Shire Llc |
Novedosos compuestos farmacéuticos de liberación sostenida para prevenir el abuso de sustancias controladas
|
US7700561B2
(en)
*
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
EP2266590A3
(de)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
|
US7105486B2
(en)
*
|
2002-02-22 |
2006-09-12 |
New River Pharmaceuticals Inc. |
Abuse-resistant amphetamine compounds
|
US20050226821A1
(en)
*
|
2002-02-22 |
2005-10-13 |
Jacob Waugh |
Cosmetic formulations containing l-arginine oligomers
|
US7659253B2
(en)
*
|
2002-02-22 |
2010-02-09 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
WO2003092736A2
(en)
*
|
2002-05-01 |
2003-11-13 |
Pantheco A/S |
Peptide nucleic acid conjugates with transporter peptides
|
SE0201863D0
(en)
*
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
US8506617B1
(en)
|
2002-06-21 |
2013-08-13 |
Advanced Cardiovascular Systems, Inc. |
Micronized peptide coated stent
|
US7033602B1
(en)
|
2002-06-21 |
2006-04-25 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of coating implantable medical devices
|
US7217426B1
(en)
|
2002-06-21 |
2007-05-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings containing polycationic peptides for cardiovascular therapy
|
US7056523B1
(en)
|
2002-06-21 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
|
US7794743B2
(en)
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
WO2004030610A2
(en)
*
|
2002-07-11 |
2004-04-15 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for the intracellular delivery of antibodies
|
US20080171012A1
(en)
*
|
2007-01-11 |
2008-07-17 |
Phillip Messersmith |
Fouling Resistant Coatings and Methods of Making Same
|
US8911831B2
(en)
*
|
2002-07-19 |
2014-12-16 |
Northwestern University |
Surface independent, surface-modifying, multifunctional coatings and applications thereof
|
WO2004009666A2
(en)
*
|
2002-07-19 |
2004-01-29 |
The Regents Of The University Of California |
Dendrimers as molecular translocators
|
US7498349B2
(en)
|
2002-08-02 |
2009-03-03 |
Genesoft Pharmaceuticals, Inc. |
Biaryl compounds having anti-infective activity
|
US7390898B2
(en)
|
2002-08-02 |
2008-06-24 |
Immunogen Inc. |
Cytotoxic agents containing novel potent taxanes and their therapeutic use
|
BR0313197A
(pt)
|
2002-08-02 |
2005-08-09 |
Immunogen Inc |
Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
|
AU2003259848A1
(en)
*
|
2002-08-15 |
2004-03-03 |
Campbell, Samantha A |
Apicomplexan pathways, inhibitors, and drug delivery
|
EE200200531A
(et)
*
|
2002-09-17 |
2004-04-15 |
O� InBio |
Terapeutiliste rakkusisenevate antikehade saamineja kasutamine
|
EP1562931A2
(de)
|
2002-10-25 |
2005-08-17 |
Genesoft Pharmaceuticals, Inc. |
Biarylverbindungen mitantiinfektionswirkung
|
WO2004044139A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Parmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
DK1585548T3
(en)
|
2002-12-09 |
2018-09-03 |
Abraxis Bioscience Llc |
COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
|
EP1587529A4
(de)
|
2002-12-10 |
2009-08-12 |
Oscient Pharmaceuticals Corp |
Antibakterielle verbindungen mit(pyrrolcarboxamid)-(benzamid)-(imidazolcarboxamid)-motiv
|
EP1583562B1
(de)
*
|
2003-01-06 |
2011-06-15 |
Angiochem Inc. |
Angiopep-1, verwandte verbindungen, und deren verwnedungen
|
US8133881B2
(en)
|
2003-01-13 |
2012-03-13 |
Shire Llc |
Carbohydrate conjugates to prevent abuse of controlled substances
|
US7704756B2
(en)
|
2003-01-21 |
2010-04-27 |
Novartis Vaccines And Diagnostics, Inc. |
Fluorogenic dyes
|
US6969514B2
(en)
*
|
2003-02-05 |
2005-11-29 |
Soll David B |
Method for treating elevated intraocular pressure, including glaucoma
|
US7166692B2
(en)
*
|
2003-03-04 |
2007-01-23 |
Canbrex Bio Science Walkersville, Inc. |
Intracellular delivery of small molecules, proteins, and nucleic acids
|
CA2523672C
(en)
|
2003-04-29 |
2012-07-17 |
Avi Biopharma, Inc. |
Compositions for enhancing transport of molecules into cells
|
KR101170840B1
(ko)
*
|
2003-05-29 |
2012-08-03 |
샤이어 엘엘씨 |
남용 방지성 암페타민 화합물
|
US8008255B2
(en)
*
|
2003-05-30 |
2011-08-30 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
WO2005013905A2
(en)
*
|
2003-08-07 |
2005-02-17 |
Avi Biopharma, Inc. |
SENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION
|
US20050222068A1
(en)
*
|
2003-10-23 |
2005-10-06 |
Mourich Dan V |
Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
|
EP1675555A4
(de)
*
|
2003-09-30 |
2011-03-09 |
Shire Llc |
Pharmazeutische zusammensetzungen zur prävention einer überdosierung oder von missbrauch
|
US7985401B2
(en)
*
|
2003-10-31 |
2011-07-26 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
US7431915B2
(en)
*
|
2003-10-31 |
2008-10-07 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
WO2005046730A2
(en)
*
|
2003-11-12 |
2005-05-26 |
The University Of Georgia Research Foundation, Inc. |
Biotin-facilitated transport into gram negative bacteria
|
WO2005072527A2
(en)
*
|
2004-01-23 |
2005-08-11 |
Avi Biopharma, Inc. |
Antisense oligomers and methods for inducing immune tolerance and immunosuppression
|
US20050192210A1
(en)
*
|
2004-03-01 |
2005-09-01 |
Rothbard Jonathan B. |
Compositions and methods for treating diseases
|
AU2005251676B2
(en)
|
2004-03-03 |
2011-09-29 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
PT2656859E
(pt)
|
2004-03-03 |
2016-02-24 |
Revance Therapeutics Inc |
Aplicação tópica e administração transdérmica de toxinas botulínicas
|
KR100578732B1
(ko)
|
2004-03-05 |
2006-05-12 |
학교법인 포항공과대학교 |
분자 수송체로서의 이노시톨 유도체 및 이의 제조방법
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
US7402574B2
(en)
*
|
2004-03-12 |
2008-07-22 |
Avi Biopharma, Inc. |
Antisense composition and method for treating cancer
|
US20050288246A1
(en)
*
|
2004-05-24 |
2005-12-29 |
Iversen Patrick L |
Peptide conjugated, inosine-substituted antisense oligomer compound and method
|
WO2005118884A1
(en)
*
|
2004-05-28 |
2005-12-15 |
The United States Of America As Represented By The Secretary Of The Navy |
A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
DK1766012T3
(da)
*
|
2004-07-02 |
2011-09-19 |
Avi Biopharma Inc |
Antisense-antibakteriel fremgangsmåde og forbindelse
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
US8129352B2
(en)
*
|
2004-09-16 |
2012-03-06 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating ssRNA viral infection
|
US8357664B2
(en)
*
|
2004-10-26 |
2013-01-22 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating influenza viral infection
|
US7524829B2
(en)
*
|
2004-11-01 |
2009-04-28 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
US7947772B2
(en)
*
|
2004-11-10 |
2011-05-24 |
The Regents Of The University Of Michigan |
Multiphasic nano-components comprising colorants
|
US7767017B2
(en)
*
|
2004-11-10 |
2010-08-03 |
The Regents Of The University Of Michigan |
Multi-phasic nanoparticles
|
US8043480B2
(en)
*
|
2004-11-10 |
2011-10-25 |
The Regents Of The University Of Michigan |
Methods for forming biodegradable nanocomponents with controlled shapes and sizes via electrified jetting
|
EP1656951A1
(de)
*
|
2004-11-12 |
2006-05-17 |
Xigen S.A. |
Konjugate mit verbesserter Zellaufnahme
|
WO2006055531A2
(en)
*
|
2004-11-16 |
2006-05-26 |
Northwestern University |
Peptidomimetic polymers for antifouling surfaces
|
CA2596506C
(en)
|
2005-02-09 |
2021-04-06 |
Avi Biopharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
DK1988167T3
(da)
|
2005-02-17 |
2020-07-13 |
Univ Sorbonne |
Intracellulære inhiberende peptider
|
US20090016959A1
(en)
*
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
PT2360258E
(pt)
*
|
2005-02-18 |
2015-01-13 |
Angiochem Inc |
Moléculas para transportar um composto através da barreira hematoencefálica
|
ATE507236T1
(de)
|
2005-03-03 |
2011-05-15 |
Revance Therapeutics Inc |
Zusammensetzungen und methoden zur topischen anwendung und zur transdermalen verabreichung eines oligopeptids
|
US9180081B2
(en)
|
2005-03-03 |
2015-11-10 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
EP1865978A4
(de)
*
|
2005-03-21 |
2012-01-25 |
Univ Columbia |
Neue neuronale schmerzbahn
|
US20060240032A1
(en)
*
|
2005-03-31 |
2006-10-26 |
Hinrichs David J |
Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases
|
DE602006017237D1
(en)
|
2005-04-05 |
2010-11-11 |
Allergan Inc |
Clostridientoxinaktivitätstests
|
KR100699279B1
(ko)
|
2005-04-28 |
2007-03-23 |
학교법인 포항공과대학교 |
당 또는 당 유사체를 골격으로 하는 분자 수송체 및 그의제조방법
|
US7973084B2
(en)
*
|
2005-04-28 |
2011-07-05 |
Postech Academy-Industrial Foundation |
Molecular transporters based on alditol or inositol and processes for the preparation thereof
|
US20060293268A1
(en)
*
|
2005-05-05 |
2006-12-28 |
Rieder Aida E |
Antisense antiviral compounds and methods for treating foot and mouth disease
|
US7790694B2
(en)
*
|
2005-07-13 |
2010-09-07 |
Avi Biopharma Inc. |
Antisense antibacterial method and compound
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
DK2433653T3
(da)
*
|
2005-07-15 |
2019-08-19 |
Angiochem Inc |
Anvendelse af aprotininpolypeptider som bærere i farmaceutiske konjugater
|
US7538187B2
(en)
*
|
2005-08-01 |
2009-05-26 |
E. I. Du Pont De Nemours And Company |
Coloring compositions with peptide-based dispersants and binders
|
WO2007030691A2
(en)
*
|
2005-09-08 |
2007-03-15 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating picornavirus infection
|
EP1937278B1
(de)
*
|
2005-09-08 |
2012-07-25 |
AVI BioPharma, Inc. |
Antivirale antisense-verbindung und verfahren zur behandlung von picornavirus-infektion
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
WO2007038172A2
(en)
*
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Guanidinium carriers
|
WO2007038169A2
(en)
*
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Multi-valent guanidinium compounds for molecular translocation across cellular membranes and epithelial tissues
|
US7700565B2
(en)
*
|
2005-09-23 |
2010-04-20 |
Nitto Denko Corporation |
Peptide nucleic acid based guanidinium compounds
|
US8883507B2
(en)
|
2005-10-18 |
2014-11-11 |
The Regents Of The University Of Colorado |
Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
|
US8501704B2
(en)
|
2005-11-08 |
2013-08-06 |
Sarepta Therapeutics, Inc. |
Immunosuppression compound and treatment method
|
US8568740B2
(en)
*
|
2005-11-17 |
2013-10-29 |
Revance Therapeutics, Inc. |
Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
|
FI20055653A
(fi)
*
|
2005-12-08 |
2007-06-09 |
Wallac Oy |
Leimausreagenssi
|
FI20065030L
(fi)
*
|
2006-01-17 |
2007-07-18 |
Wallac Oy |
Neutraaliset leimausreagenssit ja niistä johdetut konjugaatit
|
US7732539B2
(en)
*
|
2006-02-16 |
2010-06-08 |
National Science Foundation |
Modified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives
|
WO2008069824A2
(en)
*
|
2006-02-27 |
2008-06-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for transport of molecules with enhanced release properties across biological barriers
|
US8785407B2
(en)
*
|
2006-05-10 |
2014-07-22 |
Sarepta Therapeutics, Inc. |
Antisense antiviral agent and method for treating ssRNA viral infection
|
JP2010505741A
(ja)
*
|
2006-05-10 |
2010-02-25 |
エイブイアイ バイオファーマ, インコーポレイテッド |
カチオン性のサブユニット間結合を有するオリゴヌクレオチドアナログ
|
WO2007149310A2
(en)
*
|
2006-06-16 |
2007-12-27 |
The Regents Of The University Of Michigan |
Multiphasic biofunctional nano-components and methods for use thereof
|
JP5597836B2
(ja)
|
2006-08-04 |
2014-10-01 |
ケンジー ナッシュ コーポレイション |
バイオミメティック化合物およびその合成方法
|
US8563117B2
(en)
*
|
2006-08-04 |
2013-10-22 |
Phillip B. Messersmith |
Biomimetic modular adhesive complex: materials, methods and applications therefore
|
JP2010504929A
(ja)
*
|
2006-09-27 |
2010-02-18 |
ボッティ,パオロ |
生体系への送達を高める手段及び方法
|
MX2009007068A
(es)
*
|
2006-12-29 |
2009-07-10 |
Revance Therapeutics Inc |
Composiciones y metodos de aplicacion topica y suministro transdermico de toxinas botulinicas estabilizadas con fragmentos de polipeptido provenientes de hiv-tat.
|
US20100093639A1
(en)
*
|
2006-12-29 |
2010-04-15 |
Revance Therapeutics, Inc. |
Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides
|
JP2010516707A
(ja)
*
|
2007-01-19 |
2010-05-20 |
カイ ファーマシューティカルズ インコーポレーティッド |
ペプチド組成物の安定性および送達効率を上昇させるための修飾方法
|
GB0702020D0
(en)
*
|
2007-02-02 |
2007-03-14 |
Novabiotics Ltd |
Peptides and their use
|
US8673286B2
(en)
|
2007-04-09 |
2014-03-18 |
Northwestern University |
DOPA-functionalized, branched, poly(aklylene oxide) adhesives
|
US8383092B2
(en)
*
|
2007-02-16 |
2013-02-26 |
Knc Ner Acquisition Sub, Inc. |
Bioadhesive constructs
|
US9365634B2
(en)
*
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
JP2010529843A
(ja)
*
|
2007-06-03 |
2010-09-02 |
オンコティーエックス インコーポレイテッド |
バイオマーカーおよび薬物標的としての、転写因子複合体の構成要素のがん関連アイソフォーム
|
US20100016215A1
(en)
*
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
ES2694726T3
(es)
*
|
2007-06-29 |
2018-12-26 |
Sarepta Therapeutics, Inc. |
Conjugados peptídicos específicos de tejido y métodos
|
DE102007041655A1
(de)
|
2007-09-03 |
2009-03-05 |
Medicyte Gmbh |
Vermehrung von primären Zellen und deren Verwendung
|
ES2313848B1
(es)
*
|
2007-10-24 |
2010-03-22 |
Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria |
Nuevos peptidos antivirales que impiden la union del virus a dlc8.
|
US20110160146A1
(en)
*
|
2008-02-07 |
2011-06-30 |
National Institute of Health (NIH) |
Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance
|
BR122012027456A2
(pt)
|
2008-03-14 |
2015-07-14 |
Allergan Inc |
Composição farmacêutica compreendendo sorotipo de neurotoxina botulínica a
|
TR201905480T4
(tr)
*
|
2008-04-18 |
2019-05-21 |
Angiochem Inc |
Paklitaksel, paklitaksel analogları veya paklitaksel konjugatlarının farmasötik bileşimleri ve ilgili preparasyon ve kullanım yöntemleri.
|
IL287311B1
(en)
*
|
2008-05-16 |
2024-02-01 |
Taiga Biotechnologies Inc |
Antibodies and processes for their preparation
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
WO2010011641A2
(en)
*
|
2008-07-21 |
2010-01-28 |
The Regents Of The University Of Michigan |
Microphasic micro-components and methods for controlling morphology via electrified jetting
|
EP2966084B1
(de)
|
2008-08-28 |
2018-04-25 |
Taiga Biotechnologies, Inc. |
Myc-modulatoren, verfahren zur verwendung davon und verfahren zur identifikation von mitteln zur myc-modulierung
|
EP2346896A4
(de)
|
2008-10-15 |
2014-06-25 |
Angiochem Inc |
Etoposid- und doxorubicin-konjugate zur wirkstofffreisetzung
|
CA2740316A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
BRPI0922689A2
(pt)
|
2008-12-05 |
2018-11-06 |
Angiochem Inc. |
conjugados de neurotensina ou análogos de neurotensina e usos dos mesmos
|
CA2746508A1
(en)
*
|
2008-12-17 |
2010-07-15 |
Avi Biopharma, Inc. |
Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
EP2408372B1
(de)
|
2009-03-02 |
2019-01-09 |
Seventh Sense Biosystems, Inc. |
Vorrichtungen im zusammenhang mit der entnahme von blutproben
|
US20120277629A1
(en)
|
2011-04-29 |
2012-11-01 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collection and/or manipulation of blood spots or other bodily fluids
|
US9295417B2
(en)
|
2011-04-29 |
2016-03-29 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collecting fluid from a subject
|
WO2012018486A2
(en)
|
2010-07-26 |
2012-02-09 |
Seventh Sense Biosystems, Inc. |
Rapid delivery and/or receiving of fluids
|
US9033898B2
(en)
|
2010-06-23 |
2015-05-19 |
Seventh Sense Biosystems, Inc. |
Sampling devices and methods involving relatively little pain
|
US9041541B2
(en)
|
2010-01-28 |
2015-05-26 |
Seventh Sense Biosystems, Inc. |
Monitoring or feedback systems and methods
|
US8455203B2
(en)
|
2009-03-13 |
2013-06-04 |
Allergan, Inc. |
Immuno-based retargeted endopeptidase activity assays
|
KR20200146046A
(ko)
|
2009-03-13 |
2020-12-31 |
알러간, 인코포레이티드 |
면역 기반 보툴리눔 독소 혈청형 a 활성 검정에 유용한 세포
|
DK2411043T3
(da)
|
2009-03-23 |
2013-10-21 |
Pin Pharma Inc |
Behandling af cancer med immunostimulatorisk hiv tat derivat-polypeptider
|
JP2012521279A
(ja)
|
2009-03-26 |
2012-09-13 |
ビーエル・テクノロジーズ・インコーポレイテッド |
編んでない強化された中空糸膜
|
RU2011146654A
(ru)
|
2009-04-20 |
2013-05-27 |
Ангиокем Инк. |
Способы лечения рака яичников с применением конъюгированного средства
|
EP2437772B1
(de)
|
2009-06-05 |
2017-12-06 |
13Therapeutics, Inc. |
Immunregulierende peptide und verwendungsverfahren dafür
|
US20110269665A1
(en)
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
ES2521440T3
(es)
|
2009-06-26 |
2014-11-12 |
Bl Technologies, Inc. |
Membrana de fibra hueca no trenzada reforzada con textiles
|
IN2012DN00248A
(de)
|
2009-07-02 |
2015-05-01 |
Angiochem Inc |
|
EP2454271A4
(de)
|
2009-07-15 |
2015-08-12 |
Univ California |
Peptide mit steuerbarer zellulärer aufnahme
|
ES2607954T3
(es)
*
|
2009-07-29 |
2017-04-04 |
Kai Pharmaceuticals, Inc. |
Agentes terapéuticos para reducir los niveles de hormona paratiroidea
|
EP3199634A1
(de)
|
2009-11-13 |
2017-08-02 |
Sarepta Therapeutics, Inc. |
Antivirale antisense-verbindung und verfahren zur behandlung von influenzavirusinfektion
|
US20110130465A1
(en)
*
|
2009-12-01 |
2011-06-02 |
Nerites Corporation |
Coatings for prevention of biofilms
|
JP5457813B2
(ja)
*
|
2009-12-16 |
2014-04-02 |
ルネサスエレクトロニクス株式会社 |
Adpll回路、半導体装置及び携帯情報機器
|
US20140199239A1
(en)
*
|
2010-05-17 |
2014-07-17 |
The Regents Of The University Of California |
Compositions and Methods for in Vivo Imaging
|
AU2011257980B2
(en)
|
2010-05-28 |
2016-06-30 |
Sarepta Therapeutics, Inc. |
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
US20120016308A1
(en)
|
2010-07-16 |
2012-01-19 |
Seventh Sense Biosystems, Inc. |
Low-pressure packaging for fluid devices
|
US8198429B2
(en)
|
2010-08-09 |
2012-06-12 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
US20120039809A1
(en)
|
2010-08-13 |
2012-02-16 |
Seventh Sense Biosystems, Inc. |
Systems and techniques for monitoring subjects
|
WO2012031243A2
(en)
|
2010-09-03 |
2012-03-08 |
Avi Biopharma, Inc. |
dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
|
BR112013004171A2
(pt)
|
2010-09-15 |
2016-05-10 |
Bl Technologies Inc |
processo para a fabricação de um membrana de fibra oca reforçada e conjunto precursor
|
DE102010041958A1
(de)
|
2010-10-04 |
2012-04-05 |
Medicyte Gmbh |
Geeignete Hepatozyten für in-vitro Genotoxitätstests
|
CA2807036C
(en)
|
2010-10-14 |
2018-01-16 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
WO2012050673A1
(en)
*
|
2010-10-14 |
2012-04-19 |
Wisconsin Alumni Research Foundation |
Methods for the treatment of x-linked hypophosphatemia and related disorders
|
WO2012054841A2
(en)
|
2010-10-22 |
2012-04-26 |
The Regents Of The University Of Michigan |
Optical devices with switchable particles
|
EP2637707A4
(de)
|
2010-11-09 |
2014-10-01 |
Kensey Nash Corp |
Haftverbindungen und anwendungsverfahren für herniereparatur
|
WO2012064802A1
(en)
|
2010-11-09 |
2012-05-18 |
Seventh Sense Biosystems, Inc. |
Systems and interfaces for blood sampling
|
US8529814B2
(en)
|
2010-12-15 |
2013-09-10 |
General Electric Company |
Supported hollow fiber membrane
|
JP2012131743A
(ja)
*
|
2010-12-22 |
2012-07-12 |
Kyoto Univ |
腫瘍集積型抗癌剤
|
WO2012138879A2
(en)
|
2011-04-06 |
2012-10-11 |
13Therapeutics, Inc. |
Peptides for the treatment of hearing
|
US20130158468A1
(en)
|
2011-12-19 |
2013-06-20 |
Seventh Sense Biosystems, Inc. |
Delivering and/or receiving material with respect to a subject surface
|
ES2597081T3
(es)
|
2011-04-29 |
2017-01-13 |
Seventh Sense Biosystems, Inc. |
Entrega y/o recepción de fluidos
|
KR102339196B1
(ko)
|
2011-05-05 |
2021-12-15 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
펩타이드 올리고뉴클레오타이드 접합체
|
US9161948B2
(en)
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
US10202338B2
(en)
|
2011-06-21 |
2019-02-12 |
Evologie Llc |
Topical compositions for the treatment of dermatological disorders
|
JP5940542B2
(ja)
*
|
2011-08-31 |
2016-06-29 |
国立大学法人 岡山大学 |
細胞導入ペプチドと皮膚導入促進剤とを組み合わせた皮膚導入システムおよび美白剤
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
TWI429747B
(zh)
*
|
2011-11-02 |
2014-03-11 |
Univ Nat Taiwan |
具修飾側鏈之rna病毒衍生胜肽及其用途
|
KR102271212B1
(ko)
|
2011-11-18 |
2021-07-01 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
기능적으로-변형된 올리고뉴클레오티드 및 이의 서브유니트
|
EP2782926B1
(de)
|
2011-11-24 |
2018-07-04 |
Positec Power Tools (Suzhou) Co., Ltd |
Peptidsequenzentwurf und verwendung davon für peptid-vermittelte sirna-abgabe
|
US9321014B2
(en)
|
2011-12-16 |
2016-04-26 |
Bl Technologies, Inc. |
Hollow fiber membrane with compatible reinforcements
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
US9643129B2
(en)
|
2011-12-22 |
2017-05-09 |
Bl Technologies, Inc. |
Non-braided, textile-reinforced hollow fiber membrane
|
US9022229B2
(en)
|
2012-03-09 |
2015-05-05 |
General Electric Company |
Composite membrane with compatible support filaments
|
JP6527331B2
(ja)
|
2012-03-16 |
2019-06-05 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
標的指向アミノ酸脂質
|
KR102081046B1
(ko)
|
2012-03-16 |
2020-02-25 |
메르크 파텐트 게엠베하 |
아미노산 지질
|
US8999454B2
(en)
|
2012-03-22 |
2015-04-07 |
General Electric Company |
Device and process for producing a reinforced hollow fibre membrane
|
CA2870711A1
(en)
*
|
2012-04-17 |
2013-10-24 |
Brown University |
Neuroprotective composition and method of use
|
US9816066B2
(en)
|
2012-04-24 |
2017-11-14 |
The Regents Of The University Of California |
Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters
|
CN114645015A
(zh)
|
2012-07-20 |
2022-06-21 |
泰加生物工艺学公司 |
造血区室的增强的重建和自动重建
|
WO2014026283A1
(en)
|
2012-08-14 |
2014-02-20 |
Angiochem Inc. |
Peptide-dendrimer conjugates and uses thereof
|
US9227362B2
(en)
|
2012-08-23 |
2016-01-05 |
General Electric Company |
Braid welding
|
US20150291958A1
(en)
|
2012-11-15 |
2015-10-15 |
Roche Innovation Center Copenhagen A/S |
Anti apob antisense conjugate compounds
|
US10029017B2
(en)
|
2013-01-29 |
2018-07-24 |
The Regents Of The University Of California |
Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug
|
WO2014118272A1
(en)
|
2013-01-30 |
2014-08-07 |
Santaris Pharma A/S |
Antimir-122 oligonucleotide carbohydrate conjugates
|
RU2018108405A
(ru)
|
2013-01-30 |
2019-02-26 |
Ф. Хоффманн-Ля Рош Аг |
Конъюгаты углевода и lna-олигонуклеотида
|
CN105102484B
(zh)
|
2013-01-30 |
2020-03-10 |
艾维拉斯生物科学公司 |
选择性递送分子及使用方法
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
CN103739674A
(zh)
*
|
2013-04-01 |
2014-04-23 |
中国人民解放军军事医学科学院野战输血研究所 |
系列低分子鱼精蛋白模拟肽及其应用
|
US10370415B2
(en)
|
2013-04-11 |
2019-08-06 |
Carnegie Mellon University |
Divalent nucleobase compounds and uses therefor
|
US10221216B2
(en)
|
2013-04-11 |
2019-03-05 |
Carnegie Mellon University |
Template-directed γPNA synthesis process and γPNA targeting compounds
|
KR101447901B1
(ko)
*
|
2013-04-16 |
2014-10-16 |
한양대학교 산학협력단 |
지방세포 표적 비바이러스성 유전자 전달체
|
EA201501080A1
(ru)
|
2013-06-26 |
2016-07-29 |
Ксижен Инфлемейшн Лтд. |
Новое применение обладающих способностью проникать в клетку пептидных ингибиторов пути трансдукции сигнала jnk для лечения различных заболеваний
|
WO2015197097A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
EP3591054A1
(de)
|
2013-06-27 |
2020-01-08 |
Roche Innovation Center Copenhagen A/S |
Gegen pcsk9 gerichtete antisense-oligomere und konjugate
|
WO2015051245A1
(en)
|
2013-10-04 |
2015-04-09 |
Pin Pharma, Inc. |
Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment
|
GB201401453D0
(en)
*
|
2014-01-28 |
2014-03-12 |
Univ Birmingham |
Transmucosal and transepithelial drug delivery system
|
GB201401877D0
(en)
*
|
2014-02-04 |
2014-03-19 |
Univ Tromsoe |
Peptides
|
EP2927685A1
(de)
|
2014-04-02 |
2015-10-07 |
Medicyte GmbH |
Geeignete Hepatozyten für In-vitro-Hepatitistests
|
GB201408623D0
(en)
|
2014-05-15 |
2014-07-02 |
Santaris Pharma As |
Oligomers and oligomer conjugates
|
KR20160001419A
(ko)
*
|
2014-06-27 |
2016-01-06 |
포항공과대학교 산학협력단 |
양이온성 분자 수송체 및 음이온성 생리활성 물질을 포함하는 피부 투과용 조성물
|
US11072681B2
(en)
|
2014-07-28 |
2021-07-27 |
The Regents Of The University Of California |
Compositions and methods of making polymerizing nucleic acids
|
US10980744B2
(en)
|
2014-08-08 |
2021-04-20 |
The Regents Of The University Of California |
High density peptide polymers
|
US10385380B2
(en)
|
2014-10-02 |
2019-08-20 |
The Regents Of The University Of California |
Personalized protease assay to measure protease activity in neoplasms
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
US10596259B2
(en)
|
2015-05-20 |
2020-03-24 |
The Regents Of The University Of California |
Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
|
US11020417B2
(en)
|
2015-06-04 |
2021-06-01 |
Sarepta Therapeutics, Inc |
Methods and compounds for treatment of lymphocyte-related diseases and conditions
|
CA2989400A1
(en)
|
2015-06-15 |
2016-12-22 |
Angiochem Inc. |
Ang1005 for the treatment of leptomeningeal carcinomatosis
|
KR20180084782A
(ko)
|
2015-10-14 |
2018-07-25 |
엑스-써마 인코포레이티드 |
얼음 결정 형성을 감소시키기 위한 조성물 및 방법
|
ES2857702T3
(es)
|
2016-03-14 |
2021-09-29 |
Hoffmann La Roche |
Oligonucleótidos para la reducción de la expresión de PD-L1
|
WO2018058091A1
(en)
|
2016-09-26 |
2018-03-29 |
Carnegie Mellon University |
Divalent nucleobase compounds and uses therefor
|
US10583156B2
(en)
|
2016-12-02 |
2020-03-10 |
Taiga Biotechnologies, Inc. |
Nanoparticle formulations
|
BR112019012647A2
(pt)
|
2016-12-19 |
2019-11-19 |
Sarepta Therapeutics Inc |
conjugados de oligômero de salto de éxon para distrofia muscular
|
FR3064364A1
(fr)
*
|
2017-03-27 |
2018-09-28 |
S.P.C.M. Sa |
Methode de dosage de polymeres cationiques
|
WO2019018350A1
(en)
|
2017-07-17 |
2019-01-24 |
Keith Roizman |
TOPICAL ADMINISTRATION OF THERAPEUTIC AGENTS COMPRISING CELL PENETRATION PEPTIDES, FOR USE IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
CN108822052A
(zh)
*
|
2018-05-18 |
2018-11-16 |
中国科学技术大学 |
非肽类多胍小分子和基于非肽类多胍小分子-蛋白质偶联体的蛋白质运输技术
|
WO2019245353A1
(ko)
*
|
2018-06-22 |
2019-12-26 |
재단법인 대구경북과학기술원 |
사이토카인 융합 폴리펩티드, 및 이를 포함하는 사이토카인 라이브러리
|
GB201900728D0
(en)
*
|
2019-01-18 |
2019-03-06 |
Univ Birmingham |
Drug delivery system
|
KR20200110576A
(ko)
*
|
2019-03-15 |
2020-09-24 |
재단법인대구경북과학기술원 |
사이토카인 기반 면역세포 및 그의 면역 치료 용도
|
JPWO2021002408A1
(de)
|
2019-07-02 |
2021-01-07 |
|
|
WO2023048236A1
(ja)
|
2021-09-22 |
2023-03-30 |
Agc株式会社 |
ペプチド
|